Literature DB >> 11477531

Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needlestick injury.

P Morand1, N Dutertre, H Minazzi, J Burnichon, M Pernollet, M Baud, J P Zarski, J M Seigneurin.   

Abstract

We present a case of documented acute hepatitis C that occurred in a health care worker who sustained a needlestick injury while caring for an individual who was infected with both hepatitis C virus (HCV) and human immunodeficiency virus (HIV). According to the findings of third-generation serological assays performed during a follow-up of >1 year, the health care worker, who was treated with interferon-alpha (during weeks 2-6) and ribavirin (during weeks 5-9), did not develop antibodies against HCV, in spite of documentation of an HCV-specific T cell response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477531     DOI: 10.1086/322619

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  Comparison of monolisa HCV Ag/Ab ULTRA with two anti-HCV assays for the detection of HCV infection in hospital setting.

Authors:  Server Yagci; Elizaveta Padalko
Journal:  Curr Microbiol       Date:  2011-11-11       Impact factor: 2.188

2.  Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals.

Authors:  A Schnuriger; S Dominguez; M-A Valantin; R Tubiana; C Duvivier; J Ghosn; A Simon; C Katlama; V Thibault
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  High levels of subgenomic HCV plasma RNA in immunosilent infections.

Authors:  Flavien Bernardin; Susan L Stramer; Barbara Rehermann; Kimberly Page-Shafer; Stewart Cooper; David R Bangsberg; Judith Hahn; Leslie Tobler; Michael Busch; Eric Delwart
Journal:  Virology       Date:  2007-05-09       Impact factor: 3.616

Review 4.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

5.  Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users.

Authors:  M Zeremski; M A Shu; Q Brown; Y Wu; D C Des Jarlais; M P Busch; A H Talal; B R Edlin
Journal:  J Viral Hepat       Date:  2008-07-17       Impact factor: 3.728

Review 6.  Seronegative hepatitis C virus infection.

Authors:  Justyna Kaźmierczak; Agnieszka Pawełczyk; Kamila Caraballo Cortes; Marek Radkowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-09       Impact factor: 4.291

7.  Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt.

Authors:  Aline Munier; Diaa Marzouk; Florence Abravanel; Mai El-Daly; Sylvia Taylor; Rasha Mamdouh; Waleed Salah Eldin; Hanan Ezz El-Arab; Dalia Gaber Sos; Mohamed Momen; Omar Okasha; Lenaig Le Fouler; Mostafa El-Hosini; Jacques Izopet; Mona Rafik; Matthew Albert; Mohamed Abdel-Hamid; Mostafa Kamal Mohamed; Elisabeth Delarocque-Astagneau; Arnaud Fontanet
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.